- Acute cardiac conditions
- Chronic cardiac conditions
- Cardiac toxicity from anticancer therapies
- What happens when things go wrong?
In light of strict social distancing and restricted footfall measures at The Christie, we are excited to extend our offering of 'virtual' learning and live streaming for our forthcoming programmes.
Clinical practitioners, practitioners in training and Allied Health Professionals working at an advanced level.
AstraZeneca is a global, science-led pharmaceutical company, focused on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of unmet medical need in three main therapy areas:
Oncology; Cardiovascular, Renal and Metabolism (CVRM); and Respiratory and Immunology.
Cardiovascular, Renal and Metabolism
We are committed to defining new standards of care for patients with cardiovascular disease, heart failure, metabolic diseases, such as diabetes and non-alcoholic steatohepatitis (NASH), and chronic kidney disease (CKD), improving their outcomes and decreasing mortality rates.
We have built knowledge and invested in key technologies to develop both our pipeline and our level of scientific expertise. We couple this with a patient-centric approach aimed at better understanding the interplay and potential causal relationship between these diseases, which often present in the same patient.
Our approach is opening up unprecedented opportunities for novel treatment paradigms to help more patients and strengthen our pipeline with further differentiated medicines.
Sign up to our education events mailing list to be kept up to date with this and future events